Primary prophylaxis for venous thromboembolism in ambulatory cancer patients: a systematic review and network meta-analysis

Zechang Xin, Fei Liu, Yan Ping Du, Feiyu Mao, Xiaodong Wang, Peng Xu, Zhennan Li, Jianjun Qian, Jie YaoAnnals 2020 · DOI

Abstract

Anticoagulation therapies in ambulatory cancer patients can significantly reduce the risk of VTE. However, this protective effect was associated with a significantly increased risk of major bleeding. Apixaban at the appropriate dose can decrease the risk of VTE without increasing the bleeding risk. These findings require validation in larger study cohorts.
BibTeX
@article{xin2020primary,
  author = {Zechang Xin and Fei Liu and Yan Ping Du and Feiyu Mao and Xiaodong Wang and Peng Xu and Zhennan Li and Jianjun Qian and Jie Yao},
  title = {{Primary prophylaxis for venous thromboembolism in ambulatory cancer patients: a systematic review and network meta-analysis}},
  journal = {Annals},
  year = {2020},
  doi = {10.21037/apm-20-47},
}

Loading related content...

Figure